Pharmaceuticals, Biotechnology and Life Sciences
Transgene, a company focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases, announced the launch and terms of a share capital increase with shareholders’ preferential subscription rights for a total gross amount of circa €48 million, issue premium included (the “Rights Issue”).
The National Cancer Institute (NCI) awarded ATCC, a global player in biological materials management and standards, a contract to distribute a new generation of …
European Commission (EC) has granted Marketing Authorization of ONIVYDE, also known as nal-IRI or MM-398, for the treatment of metastatic adenocarcinoma of the pancreas, in combination with 5-fluorouracil (5-FU) and leucovorin (LV), in adult patients who have progressed following gemcitabine-based therapy.
Advanced Oncotherapy , the developer of proton therapy systems for cancer treatment, has announced on Tuesday that planning permission for the Harley Street site was granted.
SuperSonic Imagine has announced its sales for the third quarter to September 30, 2016.
KEOPSYS Group holding company, acquired for € 5 million, 93.8% of the capital of EURODYNE, which holds 1,184,513 QUANTEL shares and 1,928,579 voting rights, representing 14.6% of the capital and 21.3% of the voting rights of QUANTEL.
Johnson & Johnson has reported on Tuesday net earnings and diluted earnings per share for the third quarter of 2016 of$4.3 billion and $1.53, respectively. Third quarter 2015 net earnings included …
EOS imaging announced the recent entry into the North African market with the opening of two EOS sites in Tunisia.
TxCell SA has appointed Li Zhou, PhD, as Vice President, Cell Engineering.
SAFE ORTHOPAEDICS has released its revenue for the first nine months of 2016 at September 30, 2016.